Ajanta Pharma Share Price

₹ 3,396.30

-₹112.50 (-3.21%)
1D
Last updated 02 Nov, 2026, 15:57 IST
NSE: AJANTPHARM
|
Pharmaceuticals

Ajanta Pharma Share Price Today

As of 2 Nov 2026, Ajanta Pharma share price is ₹3,396.30. The stock opened at ₹3,477.30, compared to its previous close of ₹3,508.80. During today's trading session, Ajanta Pharma share price moved in the range of ₹3,321.00 to ₹3,477.80, with an average price of ₹3,399.40 for the day. Looking at its last 52-week, the stock has touched a low of ₹2,430.00 and a high of ₹3,796.00. On the performance front, Ajanta Pharma share price has increased by 20.32% over the last six months and is up 37.76% on a year-on-year basis.

Share price over the last 1 day fell from 3446.50 to 3400.00, ranging between 3335.50 and 3446.50.
₹3,321.00
3.21% down today
₹3,477.80
1D LOW
1D HIGH

Ajanta Pharma Stock Insights

Latest Earning
Op Profit TrendUp by 19.77% QoQ
Latest Earning
Net Profit TrendUp by 16.13% QoQ
Latest Earning
Revenue TrendUp by 7.94% QoQ
Stock Performance
OutperformingBeat Nifty by 6.72 % in last 3 month
Shareholding Pattern
PromoterPromoter decreased stake by 0.02%
Shareholding Pattern
DIIDII increased stake by 8.08%
Shareholding Pattern
FIIFII decreased stake by 0.72%
Technical Indicators
Volume SpikeVolume is 476.0% above 20-day average on 1 Day interval.
Ajanta Pharma stock performance
Open₹3,477.30
High₹3,477.80
Low₹3,321.00
Prev. close₹3,508.80
Ajanta Pharma trading activity
Volume3,91,996
Average traded price₹3,404.51
Last traded time03:57:12 02 Nov
Last traded quantity1
Circuit
L
H
₹2,807.10
₹4,210.50
52-week
L
H
₹2,430.00
₹3,796.00
Mkt Cap Cr
43,890.61
P/E
34.76
P/B
9.03
ROA
19.65%
ROE
25.99%
ROCE
33.9%
Quick Ratio
1.98
EV/EBITDA
23.34

Based on fundamentals, this stock's

Performance: 2 out of 5, Poor
Performance
Poor
Ajanta Pharma has underperformed the market
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Ajanta Pharma appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Ajanta Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Ajanta Pharma Company Background

ISIN
INE031B01049
Sector Market Cap
₹ 43,890.61 Cr

Ajanta Pharma Limited is an India-based specialty pharmaceutical company. It provides a comprehensive range of specialty branded generic products targeting a broad range of chronic and acute therapies. It is focused on branded generic businesses across India, Asia, and Africa. It has a wide range of therapeutic segments, such as cardiology, anti-diabetes, ophthalmology, dermatology, antibiotic, anti-malarial, pain, respiratory, gynecology, pediatric and general health products. Its business also consists of two verticals: the United States generics and the institutional business in Africa. Its ophthalmology products include Bimat (anti glaucoma), Nepaflam (anti-inflammatory), Softdrops (lubricant), and Olopat (anti-allergic). Its cardiology products include MET XL, Atorfit CV, Antihypertensive Cinod, Rosutor Gold, Dapalex and Vilatin. Its subsidiaries include Ajanta Pharma (Mauritius) Limited, Ajanta Pharma USA Inc., Ajanta Pharma Philippines Inc., and Ajanta Pharma Nigeria Limited.

Ajanta Pharma Financial Highlights

  • Revenue: Ajanta Pharma reported revenue of ₹5,624.93 crore in FY26 vs ₹4,742.60 crore in FY25. It showed an increase of 18.60% on a yearly basis.
  • Operating Profit: Ajanta Pharma reported an operating profit of ₹1,377.65 crore in FY26 vs ₹1,189.16 crore in FY25. It showed an increase of 15.85% on a year-on-year basis.
  • Net Profit: Ajanta Pharma reported a net profit of ₹1,056.00 crore in FY26 vs ₹920.39 crore in FY25. It showed an increase of 14.73% on a yearly basis.

Ajanta Pharma Quarterly Result Highlights

  • Ajanta Pharma reported revenue of ₹1,831.55 crore in Sep 2026, compared with ₹1,696.86 crore in Jun 2026, representing an increase of 7.94% on a quarter-on-quarter (QoQ) basis.
  • Ajanta Pharma reported an operating profit of ₹535.15 crore in Sep 2026, compared with ₹446.80 crore in Jun 2026, representing an increase of 19.77% on a quarter-on-quarter (QoQ) basis.
  • Ajanta Pharma reported a profit of ₹388.14 crore in Sep 2026, compared with ₹334.22 crore in Jun 2026, reflecting an increase of 16.13% on a QoQ basis.
  • The earnings per share (EPS) of Ajanta Pharma stood at ₹84.53 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
63.47%
FII
7.63%
Other DII
4.00%
Retail and other
6.96%
Mutual funds
17.95%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20257.98%
Mar 20268.26%
Jun 20267.68%
Sep 20267.63%

Ajanta Pharma Investment Returns

1 day
-3.21%
1 week
+0.45%
1 month
-5.16%
1 year
+37.76%
3 years
+85.72%
5 years
+131.18%

Ajanta Pharma Share Price History

Ajanta Pharma share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹3,479.00 / ₹3,508.80
+1.42%
29 Oct 26
₹3,459.80 / ₹3,459.70
-0.00%
28 Oct 26
₹3,354.00 / ₹3,459.80
+3.17%
27 Oct 26
₹3,385.00 / ₹3,353.60
-0.81%
Show more

Ajanta Pharma Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹5,452.86₹4,648.10₹4,208.71₹3,742.64
Other Income₹172.07₹94.50₹84.60₹98.64
Total Revenue₹5,624.93₹4,742.60₹4,293.31₹3,841.28
Total Expenses₹4,247.28₹3,553.44₹3,179.38₹3,096.03
Profit Before Tax₹1,377.65₹1,189.16₹1,113.93₹745.25
Tax₹321.65₹268.77₹297.76₹157.27
Profit After Tax₹1,056.00₹920.39₹816.17₹587.98
EPS - Basic₹84.53₹73.56₹64.82₹45.89
EPS - Diluted₹84.51₹73.53₹64.77₹45.89

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,377.65₹1,189.16₹1,113.93₹745.25
Income before WC changes₹1,541.11₹1,301.27₹1,196.96₹876.55
Change in Assets-₹780.61₹31.26-₹230.57-₹3.45
Change in Liabilities₹127.68₹147.67₹130.81₹70.30
Change in WC-₹652.93₹178.93-₹99.76₹66.85
Cash flow from Operations₹529.19₹1,157.23₹785.07₹792.11
Cash flow from Investing-₹428.92-₹376.52₹65.39-₹559.60
Cash flow from Financing-₹167.92-₹733.41-₹1,051.06-₹108.20
Total Cash Flow-₹67.65₹47.30-₹200.60₹124.31
Cash (Start of the year)₹175.12₹129.49₹329.83₹206.36
Cash (End of the year)₹107.47₹176.79₹129.23₹330.67

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,419.41₹2,171.92₹1,907.47₹1,845.02
Current Assets₹3,735.43₹2,843.03₹2,730.92₹2,834.00
Total Assets₹6,154.84₹5,014.95₹4,638.39₹4,679.02
Current Liabilities₹1,415.75₹996.10₹895.76₹1,139.28
Net Current Asset₹2,319.68₹1,846.93₹1,835.16₹1,694.72
Non-Current Liabilities₹212.00₹228.56₹175.27₹151.75
Equity Capital₹4,527.09₹3,790.29₹3,567.36₹3,387.99
Total Equity & Liabilities₹6,154.84₹5,014.95₹4,638.39₹4,679.02

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹4,845.92₹4,322.04₹3,971.12₹3,411.27
Other Income₹204.40₹119.87₹116.48₹132.75
Total Revenue₹5,050.32₹4,441.91₹4,087.60₹3,544.02
Total Expenses₹3,819.29₹3,261.85₹2,990.65₹2,844.17
Profit Before Tax₹1,231.03₹1,180.06₹1,096.95₹699.85
Tax₹284.21₹263.17₹289.71₹141.13
Profit After Tax₹946.82₹916.89₹807.24₹558.72
EPS - Basic₹75.79₹73.28₹64.11₹43.61
EPS - Diluted₹75.78₹73.25₹64.06₹43.61

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,231.03₹1,180.06₹1,096.95₹699.85
Income before WC changes₹1,340.16₹1,249.44₹1,146.26₹779.19
Change in Assets-₹319.20-₹42.65-₹261.95₹43.80
Change in Liabilities₹75.93₹128.84₹103.32₹38.86
Change in WC-₹243.27₹86.19-₹158.63₹82.66
Cash flow from Operations₹803.83₹1,053.80₹735.35₹736.29
Cash flow from Investing-₹399.56-₹349.60₹105.02-₹501.31
Cash flow from Financing-₹359.62-₹715.71-₹1,047.70-₹105.12
Total Cash Flow₹44.65-₹11.51-₹207.33₹129.86
Cash (Start of the year)₹48.60₹61.78₹268.85₹139.83
Cash (End of the year)₹93.25₹50.27₹61.52₹269.69

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,198.06₹1,978.19₹1,775.77₹1,753.60
Current Assets₹3,118.66₹2,576.06₹2,441.67₹2,551.19
Total Assets₹5,316.72₹4,554.25₹4,217.44₹4,304.79
Current Liabilities₹891.03₹710.72₹629.70₹907.84
Net Current Asset₹2,227.63₹1,865.34₹1,811.97₹1,643.35
Non-Current Liabilities₹202.16₹218.22₹174.17₹150.50
Equity Capital₹4,223.53₹3,625.31₹3,413.57₹3,246.45
Total Equity & Liabilities₹5,316.72₹4,554.25₹4,217.44₹4,304.79
* All values are in INR Crore
Ajanta Pharma market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
Ajanta Pharma technical summary
Bearish indicators2
Neutral indicators5
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
57.44
Neutral
ATR (14)
115.54
Neutral
STOCH(9,6)
73.55
Neutral
STOCH RSI (14)
100
Bearish
ADX(9)
28.35
Bearish
UO(9)
47.3
Neutral
ROC(12)
5.43
Bullish
WillR(14)
-26.45
Neutral
Period
Simple value
Exponential vaue
5D
3432.58
3438.49
10D
3360.55
3405.39
20D
3402.37
3412.79
50D
3491.79
3441.18
100D
3427.69
3386.83
Volume trend — traded volume by day
2 Nov3L
30 Oct9L
29 Oct0L
28 Oct0L
27 Oct1L
26 Oct1L
Average2L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Ajanta Pharma
Pharmaceuticals
Add Stock
Add Another

Ajanta Pharma Returns Calculator

Ex-date: 05 Aug 2026
Ex-date: 10 Nov 2025

Ajanta Pharma Latest News

2 months ago
Sun Pharma, Laurus Labs, Mankind Pharma, others drag Nifty Pharma down 1.6%; here’s what investors should know
3 months ago
Stocks to Watch, December 24: Infosys, HCLTech & other IT stocks, Ajanta Pharma, Coal India, Biocon, Belrise Industries, GAIL
4 months ago
Stocks to watch, June 10: Afcons Infra, NLC India, Ajanta Pharma, Emcure Pharma, Adani Green, oil-sensitives
6 months ago
Wockhardt, Ajanta Pharma, among others fuel Nifty Pharma up over 2%; what’s driving today’s gains?
6 months ago
Coforge, SRF, Tejas Networks shares surge over 8% amid heavy volumes; check full list
Showing news item 1 of 5

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

Ajanta Pharma Share Price FAQs

Please be aware that Ajanta Pharma stock prices are subject to continuous fluctuations due to various factors.